FDA Inspection 1179950 — Paola Giunti, MD PhD
The FDA completed an inspection of Paola Giunti, MD PhD on Aug 18, 2022 in London. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 18, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- London (United Kingdom)
Additional Details
Clinical Investigator (CI)